Internal Medicine, Gastroenterology · Chula Vista, CA
NPI
1841454758
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
587 3rd Ave
Chula Vista, CA, 91910
Phone (619) 382-3315
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
2,051 services
Medicare patients, 2024
508
Average age 69
Drug cost, 2024
$753K
2,499 prescriptions
Company payments, 2025
$1,537
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erick H Alayo was code G2012 (brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic), 558 times for 334 patients. In total Erick H Alayo billed 2,051 services in 22 codes, and Medicare paid $129K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 558 | 334 | $10.32 | $5,759 |
| 99214 Office E&M - Established | Office | 354 | 232 | $94.45 | $33K |
| 99152 Anesthesia | Facility | 273 | 230 | $8.66 | $2,364 |
| 99204 Office E&M - New | Office | 178 | 178 | $113.46 | $20K |
| 99213 Office E&M - Established | Office | 170 | 87 | $66.27 | $11K |
| 43239 Upper GI Endoscopy | Facility | 136 | 135 | $100.51 | $14K |
| 45385 Colonoscopy - Lesion Removal | Facility | 73 | 73 | $200.01 | $15K |
| 99203 Office E&M - New | Office | 71 | 71 | $77.76 | $5,521 |
| 99212 Office E&M - Established | Office | 65 | 37 | $41.64 | $2,707 |
| 45380 Lower GI Endoscopy - Other | Facility | 54 | 54 | $82.10 | $4,433 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 32 | 32 | $185.65 | $5,941 |
| 76981 Ultrasound - Nonspecific | Office | 24 | 23 | $94.13 | $2,259 |
| 76705 Ultrasound - Abdomen and Pelvis | Office | 24 | 23 | $75.66 | $1,816 |
| 45378 Lower GI Endoscopy - Other | Facility | 15 | 15 | $142.69 | $2,140 |
By year: 2022 $149K for 2,240 services; 2023 $125K for 1,921 services; 2024 $129K for 2,051 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erick H Alayo prescribed most often to Medicare patients was Omeprazole, with 455 prescriptions and refills. In total Erick H Alayo wrote 2,499 Medicare prescriptions that cost $753K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 455 | 628 | 201 | $5,537 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 408 | 408 | 392 | $6,213 |
| Trulance Plecanatide | 282 | 298 | 70 | $164K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 233 | 233 | 221 | $3,441 |
| Linzess Linaclotide | 217 | 239 | 74 | $127K |
| Famotidine Generic | 195 | 277 | 85 | $2,040 |
| Sucralfate Generic | 131 | 246 | 59 | $7,891 |
| Pantoprazole Sodium Generic | 102 | 157 | 35 | $1,120 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 72 | 72 | 67 | $4,204 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 45 | 45 | 41 | $7,175 |
| Talicia Omeprazole/Amoxicill/Rifabutin | 37 | 37 | 37 | $28K |
| Mesalamine Generic | 32 | 34 | Under 11 | $10K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 32 | 32 | 30 | $546 |
| Vemlidy Tenofovir Alafenamide | 32 | 32 | Under 11 | $48K |
| Entecavir Generic | 22 | 22 | Under 11 | $7,375 |
Brand drugs: - claims; generic drugs: 1,547 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erick H Alayo $1,537 ($1,537 in general payments such as food, travel and fees) from 13 companies. The largest payer was Madrigal Pharmaceuticals with $606.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 10 | $606 |
| Gilead Sciences, Inc. GILD | 5 | $233 |
| Novo Nordisk Inc NVO | 5 | $185 |
| Abbvie Inc. ABBV | 11 | $174 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $38.58 |
| Pfizer Inc. PFE | 1 | $31.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.